Synergy CHC Corp. Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax
Synergy CHC Corp. (SNYR) reported Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax of $1.94 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax · last filed 2025-05-15
- Synergy CHC Corp. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2025-03-31 was $1.94K.
- Synergy CHC Corp. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2024-12-31 was $53.66K, a 55.51% decline year-over-year.
- Synergy CHC Corp. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2024-09-30 was $79.03K.
- Synergy CHC Corp. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2024-03-31 was -$131.64K.
- Synergy CHC Corp. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2024 was -$54.69K, a 143.80% decline from fiscal 2023.
- Synergy CHC Corp. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2023 was $124.86K.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 3 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 6 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 9 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 12 month |
|---|---|---|---|---|
| 2025-03-31 | $1.94K 10-Q · filed 2025-05-15 | $55.59K derived: sum of 2 quarters · filed 2025-05-15 | $134.62K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2024-12-31 | $53.66K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $132.68K derived: sum of 2 quarters · filed 2025-03-31 | -$54.69K 10-K · filed 2025-03-31 | |
| 2024-09-30 | $79.03K 10-Q · filed 2024-12-06 | -$108.35K 10-Q · filed 2024-12-06 | ||
| 2024-03-31 | -$131.64K 10-Q · filed 2025-05-15 | -$11.04K derived: sum of 2 quarters · filed 2025-05-15 | -$116.44K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $120.60K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $15.20K derived: sum of 2 quarters · filed 2025-03-31 | $124.86K 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$105.40K 10-Q · filed 2024-12-06 | $4.26K 10-Q · filed 2024-12-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |